Zynex Stock News

Zynex, Inc. (NASDAQ:ZYXI ) Q1 2022 Earnings Conference Call April 28, 2022 4:15 PM ET Company Participants Louisa Smith – Investor Relations-Gilmartin Group Thomas Sandgaard – Chairman, President

Zynex Inc. (ZYXI) delivered earnings and revenue surprises of -40% and 0.66%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ENGLEWOOD, Colo. , April 18, 2022 /PRNewswire/ -- April 18, 2022 – Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medic

Zynex Inc. (NASDAQ:ZYXI)’s traded shares stood at 0.38 million during the last session, with the company’s beta value hitting 0.93. At the close of trading, the stock’s price was $5.28, to imply a decrease of -6.71% or -$0.38 in intraday trading. The ZYXI share’s 52-week high remains $16.10, putting it -204.92% down since that peak … Zynex Inc. (NASDAQ: ZYXI) Has Succeeded In Gaining Momentum In 2022, The Stock Is Down -41.16% YTD Read More »

Zynex Inc. (ZYXI) delivered earnings and revenue surprises of 21.05% and 1.69%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zynex, Inc's. (ZYXI) CEO Thomas Sandgaard on Q4 2021 Results - Earnings Call Transcript

Zynex press release (ZYXI): Q4 GAAP EPS of $0.23 beats by $0.04.Revenue of $40.37M (+57.7% Y/Y) misses by $0.95M.Q1 revenue to be in the range of $29M-$32M vs

Zynex (NASDAQ:ZYXI) is scheduled to announce Q4 earnings results on Thursday, February 24th, after market close.The consensus EPS Estimate is $0.18 (+260.0% Y/Y) and the consensus…

Zynex (ZYXI) rules out any material impact to the company topline after United Health Care dropped its coverage for the pain-related healthcare equipment company.In response to what…

Zynex stock is down 19% in afternoon trading and hit a 52-week low of $5.62 earlier.

ENGLEWOOD, Colo. , Feb. 8, 2022 /PRNewswire/ -- Zynex, Inc . (( ZYXI ), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the company will report fourth quarter and full-year 2021 financial results on Thursday, February 24, 2022 . Zynex''s management will host a conference call and webcast at 2:15 p.m. MT / 4:15 p.m. ET that day to discuss the financial results and provide a corporate update. Webcast Details: Thursday, February 24, 2022 at 2:15 p.m. MT / 4:15 p.m. ET To register and participate in the webcast, interested parties should click Full story available on Benzinga.com

Zynex Inc (ZYXI) shares closed today at 0.4% above its 52 week low of $8.11, giving the company a market cap of $283M. The stock is currently down 9.3% year-to-date, down 45.3% over the past 12 months, and up 4204.6% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Trading volume this week was 20.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -231.3% The company's stock price performance over the past 12 months lags the peer average by 63.2% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Zynex Inc (ZYXI) shares closed 1.3% lower than its previous 52 week low, giving the company a market cap of $292M. The stock is currently down 6.4% year-to-date, down 37.2% over the past 12 months, and up 4342.1% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 20.5% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 3.9% lower than its 5-day moving average, 14.9% lower than its 20-day moving average, and 31.3% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -184.8% The company's stock price performance over the past 12 months lags the peer average by 25.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.